Targeted News Service

Client Monte Rosa Therapeutics Enters Collaboration with Novartis for Molecular Glue Degraders
September 15, 2025

BOSTON, Massachusetts, Sept. 15 [Category: BizLaw/Legal] -- Ropes and Gray, a law firm, issued the following news:

* * *

Client Monte Rosa Therapeutics Enters Collaboration with Novartis for Molecular Glue Degraders

*

Ropes & Gray advised Monte Rosa Therapeutics in a collaboration agreement with Novartis to develop novel molecular glue degrader-based medicines for immune diseases in a deal worth up to $5.7 billion. Monte Rosa will conduct d . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form